Essentials of bladder cancer worldwide: incidence, mortality rate and risk factors
DOI:
https://doi.org/10.15419/bmrat.v4i9.371Keywords:
Bladder cancer, Incidence, Mortality, Patient, Risk Factor, World, MedicineAbstract
Bladder cancer (BC) is the sixth most common cancer in the world. An increase in the incidence and recurrence of BC has led to massive pressure on health care systems. Studies have shown that the geographical and ethical distributions of BC are variable in different parts of the world. However, most studies have focused more on clinical challenges and treatment strategies in BC management. Due to the limited number of studies conducted on the incidence rate, mortality and risk factors of BC worldwide, it is necessary to carry out studies in these areas. Therefore, the aim of this study was to determine the global incidence rate, mortality rate and risk factors for BC.
References
<ol>
<li class="show">[Internet] (2017). Bladder Cancer . The Scripps Research Institute.</li>
<li class="show">Abern, M.R., Dude, A.M., Tsivian, M., and Coogan, C.L. (2013). The characteristics of bladder cancer after radiotherapy for prostate cancer. Paper presented at: Urologic Oncology: Seminars and Original Investigations (Elsevier). <a href="https://doi.org/10.1016/j.urolonc.2012.04.006">https://doi.org/10.1016/j.urolonc.2012.04.006</a></li>
<li class="show">Aglianò, A. M., Gradilone, A., Gazzaniga, P., Napolitano, M., Vercillo, R., Albonici, L., . . . Vecchione, A. (1994). High frequency of human papillomavirus detection in urinary bladder cancer. Urologia Internationalis, 53(3), 125–129. <a href="https://doi.org/10.1159/000282652">https://doi.org/10.1159/000282652</a></li>
<li class="show">Alberg, A. J., & Hébert, J. R. (2009). Cigarette smoking and bladder cancer: a new twist in an old saga? Oxford University Press.</li>
<li class="show">Amin, M. B., Smith, S. C., Eble, J. N., Rao, P., Choi, W. W., Tamboli, P., & Young, R. H. (2014). Glandular neoplasms of the urachus: A report of 55 cases emphasizing mucinous cystic tumors with proposed classification. The American Journal of Surgical Pathology, 38(8), 1033–1045.</li>
<li class="show">Antoni, S., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A., & Bray, F. (2017). Bladder cancer incidence and mortality: A global overview and recent trends. European Urology, 71(1), 96–108. <a href="https://doi.org/10.1016/j.eururo.2016.06.010">https://doi.org/10.1016/j.eururo.2016.06.010</a></li>
<li class="show">Baithun, S., Daruwala, P., & Oliver, R. T. (1998). Squamous change in bladder cancer and its relevance to understanding clonal evolution in development of bladder cancer. Cancer Surveys, 31, 17–27.</li>
<li class="show">Barghi, M. R., Rahjoo, T., Borghei, M., Hosseini-Moghaddam, S. M., Amani, D., & Farrokhi, B. (2012). Association between the evidence of human papilloma virus infection in bladder transitional cell carcinoma in men and cervical dysplasia in their spouses. Archives of Iranian Medicine, 15(9), 572–574.</li>
<li class="show">Baris, D., Karagas, M. R., Verrill, C., Johnson, A., Andrew, A. S., Marsit, C. J., . . . Silverman, D. T. (2009). A case-control study of smoking and bladder cancer risk: Emergent patterns over time. Journal of the National Cancer Institute, 101(22), 1553–1561.<a href=" https://doi.org/10.1093/jnci/djp361"> https://doi.org/10.1093/jnci/djp361</a></li>
<li class="show">Bosetti, C., Bertuccio, P., Chatenoud, L., Negri, E., La Vecchia, C., & Levi, F. (2011). Trends in mortality from urologic cancers in Europe, 1970-2008. European Urology, 60(1), 1–15. <a href="https://doi.org/10.1016/j.eururo.2011.03.047">https://doi.org/10.1016/j.eururo.2011.03.047</a></li>
<li class="show">Botelho, M., Ferreira, A. C., Oliveira, M. J., Domingues, A., Machado, J. C., & da Costa, J. M. C. (2009). Schistosoma haematobium total antigen induces increased proliferation, migration and invasion, and decreases apoptosis of normal epithelial cells. International Journal for Parasitology, 39(10), 1083–1091. <a href="https://doi.org/10.1016/j.ijpara.2009.02.016">https://doi.org/10.1016/j.ijpara.2009.02.016</a></li>
<li class="show">Botelho, M.C., Oliveira, P.A., Lopes, C., da Costa, J.M.C., and Machado, J.C. (2011). Urothelial dysplasia and inflammation induced by Schistosoma haematobium total antigen instillation in mice normal urothelium. Paper presented at: Urologic Oncology: Seminars and Original Investigations (Elsevier). <a href="https://doi.org/10.1016/j.urolonc.2009.09.017">https://doi.org/10.1016/j.urolonc.2009.09.017</a></li>
<li class="show">Brinkman, M. T., Karagas, M. R., Zens, M. S., Schned, A., Reulen, R. C., & Zeegers, M. P. (2010). Minerals and vitamins and the risk of bladder cancer: Results from the New Hampshire Study. Cancer Causes & Control, 21(4), 609–619. <a href="https://doi.org/10.1007/s10552-009-9490-0">https://doi.org/10.1007/s10552-009-9490-0</a></li>
<li class="show">Brown, A.P., Neeley, E.S., Werner, T., Soisson, A.P., Burt, R.W., and Gaffney, D.K. (2010). A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations. International Journal of Radiation Oncology* Biology* Physics 78, 127-135.<a href=" https://doi.org/10.1016/j.ijrobp.2009.07.1692"> https://doi.org/10.1016/j.ijrobp.2009.07.1692</a></li>
<li class="show">Burger, M., Catto, J. W., Dalbagni, G., Grossman, H. B., Herr, H., Karakiewicz, P., . . . Lotan, Y. (2013). Epidemiology and risk factors of urothelial bladder cancer. European Urology, 63(2), 234–241. <a href="https://doi.org/10.1016/j.eururo.2012.07.033">https://doi.org/10.1016/j.eururo.2012.07.033</a></li>
<li class="show">Carreón, T., Hein, M. J., Viet, S. M., Hanley, K. W., Ruder, A. M., & Ward, E. M. (2010). Increased bladder cancer risk among workers exposed to o-toluidine and aniline: A reanalysis. Occupational and Environmental Medicine, 67(5), 348–350. <a href="https://doi.org/10.1136/oem.2009.051136">https://doi.org/10.1136/oem.2009.051136</a></li>
<li class="show">Case, R. A., & Hosker, M. E. (1954). Tumour of the urinary bladder as an occupational disease in the rubber industry in England and Wales. British Journal of Preventive & Social Medicine, 8(2), 39–50.<br>Chavan, S., Bray, F., Lortet-Tieulent, J., Goodman, M., & Jemal, A. (2014). International variations in bladder cancer incidence and mortality. European Urology, 66(1), 59–73. <a href="https://doi.org/10.1016/j.eururo.2013.10.001">https://doi.org/10.1016/j.eururo.2013.10.001</a></li>
<li class="show">Chen, C.-H., Dickman, K. G., Moriya, M., Zavadil, J., Sidorenko, V. S., Edwards, K. L., . . . Grollman, A. P. (2012). Aristolochic acid-associated urothelial cancer in Taiwan. Proceedings of the National Academy of Sciences of the United States of America, 109(21), 8241–8246.<a href=" https://doi.org/10.1073/pnas.1119920109"> https://doi.org/10.1073/pnas.1119920109</a></li>
<li class="show">Chen, C. H., Dickman, K. G., Huang, C. Y., Moriya, M., Shun, C. T., Tai, H. C., . . . Pu, Y. S. (2013). Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes. International Journal of Cancer, 133(1), 14–20. <a href="https://doi.org/10.1002/ijc.28013">https://doi.org/10.1002/ijc.28013</a></li>
<li class="show">Chen, H.-I., Chi, T.-C., Ko, S.-Y., Hsu, Y.-C., Lin, I.-H., Chen, A., . . . Li, C.-F. (2014). 4, 4′-Methylenebis (2-chloroaniline)(MBOCA) May Be Highly Toxic and a Carcinogen Based on an Experimental Study with Mice. Advances in Biological Chemistry, 4(03), 203–213. <a href="https://doi.org/10.4236/abc.2014.43025">https://doi.org/10.4236/abc.2014.43025</a></li>
<li class="show">Chen, W., Clements, M., Rahman, B., Zhang, S., Qiao, Y., & Armstrong, B. K. (2010). Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China. Cancer Causes & Control, 21(10), 1701–1709. <a href="https://doi.org/10.1007/s10552-010-9599-1">https://doi.org/10.1007/s10552-010-9599-1</a></li>
<li class="show">Chiu, H.-F., Tsai, S.-S., & Yang, C.-Y. (2007). Nitrate in drinking water and risk of death from bladder cancer: An ecological case-control study in Taiwan. Journal of Toxicology and Environmental Health. Part A., 70(12), 1000–1004. <a href="https://doi.org/10.1080/15287390601171801">https://doi.org/10.1080/15287390601171801</a></li>
<li class="show">Chow, W.-H., Dong, L. M., & Devesa, S. S. (2010). Epidemiology and risk factors for kidney cancer. Nature Reviews. Urology, 7(5), 245–257. <a href="https://doi.org/10.1038/nrurol.2010.46">https://doi.org/10.1038/nrurol.2010.46</a></li>
<li class="show">Clyne, M. (2013). Bladder cancer: Aristolochic acid—one of the most potent carcinogens known to man. Nature Reviews. Urology, 10(10), 552–552. <a href="https://doi.org/10.1038/nrurol.2013.186">https://doi.org/10.1038/nrurol.2013.186</a></li>
<li class="show">Colombel, M., Soloway, M., Akaza, H., Böhle, A., Palou, J., Buckley, R., Lamm, D., Brausi, M., Witjes, J.A., and Persad, R. (2008). Epidemiology, staging, grading, and risk stratification of bladder cancer. european urology supplements 7, 618-626.</li>
<li class="show">Colt, J.S., Karagas, M.R., Schwenn, M., Baris, D., Johnson, A., Stewart, P., Verrill, C., Moore, L.E., Lubin, J., and Ward, M.H. (2010). Occupation and bladder cancer in a population-based case–control study in Northern New England. Occupational and environmental medicine, oem. 2009.052571.</li>
<li class="show">Datta, G. D., Neville, B. A., Kawachi, I., Datta, N. S., & Earle, C. C. (2009). Marital status and survival following bladder cancer. Journal of Epidemiology and Community Health, 63(10), 807–813. <a href="https://doi.org/10.1136/jech.2008.082438">https://doi.org/10.1136/jech.2008.082438</a></li>
<li class="show">Davis-Dao, C.A., Henderson, K.D., Sullivan-Halley, J., Ma, H., West, D.W., Xiang, Y.-B., Gago-Dominguez, M., Stern, M.C., Castelao, J.E., and Conti, D.V. (2011). Lower risk in parous women suggests hormonal factors important in bladder cancer etiology. Cancer Epidemiology and Prevention Biomarkers, cebp. 0017.2011. <a href="https://doi.org/10.1158/1055-9965.EPI-11-0017">https://doi.org/10.1158/1055-9965.EPI-11-0017</a></li>
<li class="show">Dietrich, K., Demidenko, E., Schned, A., Zens, M. S., Heaney, J., & Karagas, M. R. (2011). Parity, early menopause and the incidence of bladder cancer in women: A case-control study and meta-analysis. European Journal of Cancer, 47(4), 592–599. <a href="https://doi.org/10.1016/j.ejca.2010.10.007">https://doi.org/10.1016/j.ejca.2010.10.007</a></li>
<li class="show">Emadi, A., Jones, R. J., & Brodsky, R. A. (2009). Cyclophosphamide and cancer: Golden anniversary. Nature Reviews. Clinical Oncology, 6(11), 638–647. <a href="https://doi.org/10.1038/nrclinonc.2009.146">https://doi.org/10.1038/nrclinonc.2009.146</a></li>
<li class="show">Escudero, D. O., Shirodkar, S. P., & Lokeshwar, V. B. (2011). Bladder carcinogenesis and molecular pathways. In Bladder Tumors (pp. 23–41). Springer. <a href="https://doi.org/10.1007/978-1-60761-928-4_2">https://doi.org/10.1007/978-1-60761-928-4_2</a></li>
<li class="show">Feifer, A. H., Taylor, J. M., Tarin, T. V., & Herr, H. W. (2011). Maximizing cure for muscle-invasive bladder cancer: Integration of surgery and chemotherapy. European Urology, 59(6), 978–984. <a href="https://doi.org/10.1016/j.eururo.2011.01.014">https://doi.org/10.1016/j.eururo.2011.01.014</a></li>
<li class="show">Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W., Comber, H., . . . Bray, F. (2013). Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer, 49(6), 1374–1403. <a href="https://doi.org/10.1016/j.ejca.2012.12.027">https://doi.org/10.1016/j.ejca.2012.12.027</a></li>
<li class="show">Fernández, M. I., López, J. F., Vivaldi, B., & Coz, F. (2012). Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure. The Journal of Urology, 187(3), 856–861. <a href="https://doi.org/10.1016/j.juro.2011.10.157">https://doi.org/10.1016/j.juro.2011.10.157</a></li>
<li class="show">Figueroa, J. D., Koutros, S., Colt, J. S., Kogevinas, M., Garcia-Closas, M., Real, F. X., . . . Silverman, D. T. (2015). Modification of occupational exposures on bladder cancer risk by common genetic polymorphisms. JNCI. Journal of the National Cancer Institute, 107(11), 107.<a href=" https://doi.org/10.1093/jnci/djv223"> https://doi.org/10.1093/jnci/djv223</a></li>
<li class="show">Freedman, N. D., Silverman, D. T., Hollenbeck, A. R., Schatzkin, A., & Abnet, C. C. (2011). Association between smoking and risk of bladder cancer among men and women. Journal of the American Medical Association, 306(7), 737–745. <a href="https://doi.org/10.1001/jama.2011.1142">https://doi.org/10.1001/jama.2011.1142</a></li>
<li class="show">Gago-Dominguez, M., Castelao, J. E., Yuan, J. M., Yu, M. C., & Ross, R. K. (2001). Use of permanent hair dyes and bladder-cancer risk. International Journal of Cancer, 91(4), 575–579. <a href="https://doi.org/10.1002/1097-0215(200002)9999:99993.0.CO;2-S">https://doi.org/10.1002/1097-0215(200002)9999:99993.0.CO;2-S</a></li>
<li class="show">García-Pérez, J., Pollán, M., Boldo, E., Pérez-Gómez, B., Aragonés, N., Lope, V., . . . López-Abente, G. (2009). Mortality due to lung, laryngeal and bladder cancer in towns lying in the vicinity of combustion installations. The Science of the Total Environment, 407(8), 2593–2602. <a href="https://doi.org/10.1016/j.scitotenv.2008.12.062">https://doi.org/10.1016/j.scitotenv.2008.12.062</a></li>
<li class="show">Garland, C., Shekelle, R. B., Barrett-Connor, E., Criqui, M. H., Rossof, A. H., & Paul, O. (1985). Dietary vitamin D and calcium and risk of colorectal cancer: A 19-year prospective study in men. Lancet, 1(8424), 307–309. <a href="https://doi.org/10.1016/S0140-6736(85)91082-7">https://doi.org/10.1016/S0140-6736(85)91082-7</a></li>
<li class="show">Giron, A. M., Passerotti, C. C., Nguyen, H., Cruz, J. A., & Srougi, M. (2011). Bladder exstrophy: Reconstructed female patients achieving normal pregnancy and delivering normal babies. International Braz J Urol, 37(5), 605–610. <a href="https://doi.org/10.1590/S1677-55382011000500006">https://doi.org/10.1590/S1677-55382011000500006</a></li>
<li class="show">Golka, K., Wiese, A., Assennato, G., & Bolt, H. M. (2004). Occupational exposure and urological cancer. World Journal of Urology, 21(6), 382–391. <a href="https://doi.org/10.1007/s00345-003-0377-5">https://doi.org/10.1007/s00345-003-0377-5</a></li>
<li class="show">Gulis, G., Czompolyova, M., & Cerhan, J. R. (2002). An ecologic study of nitrate in municipal drinking water and cancer incidence in Trnava District, Slovakia. Environmental Research, 88(3), 182–187. <a href="https://doi.org/10.1006/enrs.2002.4331">https://doi.org/10.1006/enrs.2002.4331</a></li>
<li class="show">Husain, E., Prowse, D. M., Ktori, E., Shaikh, T., Yaqoob, M., Junaid, I., & Baithun, S. (2009). Human papillomavirus is detected in transitional cell carcinoma arising in renal transplant recipients. Pathology, 41(3), 245–247. <a href="https://doi.org/10.1080/00313020902756303">https://doi.org/10.1080/00313020902756303</a></li>
<li class="show">Jacobs, B. L., Lee, C. T., & Montie, J. E. (2010). Bladder cancer in 2010: How far have we come? CA: a Cancer Journal for Clinicians, 60(4), 244–272. <a href="https://doi.org/10.3322/caac.20077">https://doi.org/10.3322/caac.20077</a></li>
<li class="show">Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: a Cancer Journal for Clinicians, 61(2), 69–90. <a href="https://doi.org/10.3322/caac.20107">https://doi.org/10.3322/caac.20107</a></li>
<li class="show">Jemal, A., Center, M. M., DeSantis, C., & Ward, E. M. (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology and Prevention Biomarkers, 19(8), 1893–1907. <a href="https://doi.org/10.1158/1055-9965.EPI-10-0437">https://doi.org/10.1158/1055-9965.EPI-10-0437</a></li>
<li class="show">Jomova, K., Jenisova, Z., Feszterova, M., Baros, S., Liska, J., Hudecova, D., . . . Valko, M. (2011). Arsenic: Toxicity, oxidative stress and human disease. Journal of Applied Toxicology, 31(2), 95–107.</li>
<li class="show">Karagas, M. R., Park, S., Warren, A., Hamilton, J., Nelson, H. H., Mott, L. A., & Kelsey, K. T. (2005). Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: A population-based study. Cancer Letters, 219(1), 63–69. <a href="https://doi.org/10.1016/j.canlet.2004.10.006">https://doi.org/10.1016/j.canlet.2004.10.006</a></li>
<li class="show">Kiemeney, L. A., Sulem, P., Besenbacher, S., Vermeulen, S. H., Sigurdsson, A., Thorleifsson, G., . . . Stefansson, K. (2010). A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nature Genetics, 42(5), 415–419. <a href="https://doi.org/10.1038/ng.558">https://doi.org/10.1038/ng.558</a></li>
<li class="show">Kiriluk, K.J., Prasad, S.M., Patel, A.R., Steinberg, G.D., and Smith, N.D. (2012). Bladder cancer risk from occupational and environmental exposures. Paper presented at: Urologic Oncology: Seminars and Original Investigations (Elsevier). <a href="https://doi.org/10.1016/j.urolonc.2011.10.010">https://doi.org/10.1016/j.urolonc.2011.10.010</a></li>
<li class="show">Kirkali, Z., Chan, T., Manoharan, M., Algaba, F., Busch, C., Cheng, L., . . . Weider, J. (2005). Bladder cancer: Epidemiology, staging and grading, and diagnosis. Urology, 66(6, Suppl 1), 4–34. <a href="https://doi.org/10.1016/j.urology.2005.07.062">https://doi.org/10.1016/j.urology.2005.07.062</a></li>
<li class="show">Koay, E. J., Teh, B. S., Paulino, A. C., & Butler, E. B. (2011). A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: Epidemiology, prognostic variables, and treatment trends. Cancer, 117(23), 5325–5333. <a href="https://doi.org/10.1002/cncr.26197">https://doi.org/10.1002/cncr.26197</a></li>
<li class="show">Kogevinas M, G.-C.M. (2014). Bladder cancer. In Occupational Cancers (Springer), pp. 461-480.</li>
<li class="show">Koroukian, S., Bakkaki, P., and Raghavan, D. (2010). Survival disparities by Medicaid status: An analysis of 8 cancers [abstract A-62]. Paper presented at: American Association of Cancer Research Annual Meeting, Miami, Florida.</li>
<li class="show">Lee, R. K., Abol-Enein, H., Artibani, W., Bochner, B., Dalbagni, G., Daneshmand, S., . . . Shariat, S. F. (2014). Urinary diversion after radical cystectomy for bladder cancer: Options, patient selection, and outcomes. BJU International, 113(1), 11–23. <a href="https://doi.org/10.1111/bju.12121">https://doi.org/10.1111/bju.12121</a></li>
<li class="show">Letašiová, S., Medve’ová, A., Šovčíková, A., Dušinská, M., Volkovová, K., Mosoiu, C., & Bartonová, A. (2012). Bladder cancer, a review of the environmental risk factors. Environmental Health, 11(Suppl 1), S11. <a href="https://doi.org/10.1186/1476-069X-11-S1-S11">https://doi.org/10.1186/1476-069X-11-S1-S11</a></li>
<li class="show">Levin, D., Bell, S., Sund, R., Hartikainen, S. A., Tuomilehto, J., Pukkala, E., . . . Colhoun, H. M., & the Scottish Diabetes Research Network Epidemiology Group, & the Diabetes and Cancer Research Consortium. (2015). Pioglitazone and bladder cancer risk: A multipopulation pooled, cumulative exposure analysis. Diabetologia, 58(3), 493–504. <a href="https://doi.org/10.1007/s00125-014-3456-9">https://doi.org/10.1007/s00125-014-3456-9</a></li>
<li class="show">Lewis, J. D., Ferrara, A., Peng, T., Hedderson, M., Bilker, W. B., Quesenberry, C. P., Jr., . . . Strom, B. L. (2011). Risk of bladder cancer among diabetic patients treated with pioglitazone: Interim report of a longitudinal cohort study. Diabetes Care, 34(4), 916–922. <a href="https://doi.org/10.2337/dc10-1068">https://doi.org/10.2337/dc10-1068</a></li>
<li class="show">Li, N., Yang, L., Zhang, Y., Zhao, P., Zheng, T., & Dai, M. (2011). Human papillomavirus infection and bladder cancer risk: A meta-analysis. The Journal of Infectious Diseases, 204(2), 217–223. <a href="https://doi.org/10.1093/infdis/jir248">https://doi.org/10.1093/infdis/jir248</a></li>
<li class="show">Lin, I.-S., Fan, P.-L., Chen, H.-I., Loh, C.-H., Shih, T.-S., & Liou, S.-H. (2013). Rapid and intermediate N-acetylators are less susceptible to oxidative damage among 4,4′-methylenebis(2-chloroaniline) (MBOCA)-exposed workers. International Journal of Hygiene and Environmental Health, 216(4), 515–520. <a href="https://doi.org/10.1016/j.ijheh.2013.02.001">https://doi.org/10.1016/j.ijheh.2013.02.001</a></li>
<li class="show">Mahdavifar, N., Ghoncheh, M., Pakzad, R., Momenimovahed, Z., & Salehiniya, H. (2016). Epidemiology, incidence and mortality of bladder cancer and their relationship with the development index in the world. Asian Pacific Journal of Cancer Prevention, 17(1), 381–386. <a href="https://doi.org/10.7314/APJCP.2016.17.1.381">https://doi.org/10.7314/APJCP.2016.17.1.381</a></li>
<li class="show">Melick, W. F., Escue, H. M., Naryka, J. J., Mezera, R. A., & Wheeler, E. P. (1955). The first reported cases of human bladder tumors due to a new carcinogen-xenylamine. The Journal of Urology, 74(6), 760–766. <a href="https://doi.org/10.1016/S0022-5347(17)67344-0">https://doi.org/10.1016/S0022-5347(17)67344-0</a></li>
<li class="show">Meliker, J. R., Slotnick, M. J., AvRuskin, G. A., Schottenfeld, D., Jacquez, G. M., Wilson, M. L., . . . Nriagu, J. O. (2010). Lifetime exposure to arsenic in drinking water and bladder cancer: A population-based case-control study in Michigan, USA. Cancer Causes & Control, 21(5), 745–757. <a href="https://doi.org/10.1007/s10552-010-9503-z">https://doi.org/10.1007/s10552-010-9503-z</a></li>
<li class="show">Miao, Y., Everly, J. J., Gross, T. G., Tevar, A. D., First, M. R., Alloway, R. R., & Woodle, E. S. (2009). De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation, 87(9), 1347–1359. <a href="https://doi.org/10.1097/TP.0b013e3181a238f6">https://doi.org/10.1097/TP.0b013e3181a238f6</a></li>
<li class="show">Mohr, S. B., Garland, C. F., Gorham, E. D., Grant, W. B., & Garland, F. C. (2010). Ultraviolet B irradiance and incidence rates of bladder cancer in 174 countries. American Journal of Preventive Medicine, 38(3), 296–302. <a href="https://doi.org/10.1016/j.amepre.2009.10.044">https://doi.org/10.1016/j.amepre.2009.10.044</a></li>
<li class="show">Monach, P. A., Arnold, L. M., & Merkel, P. A. (2010). Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: A data-driven review. Arthritis & Rheumatology (Hoboken, N.J.), 62(1), 9–21. <a href="https://doi.org/10.1002/art.25061">https://doi.org/10.1002/art.25061</a></li>
<li class="show">Naranmandura, H., Carew, M. W., Xu, S., Lee, J., Leslie, E. M., Weinfeld, M., & Le, X. C. (2011). Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells. Chemical Research in Toxicology, 24(9), 1586–1596. <a href="https://doi.org/10.1021/tx200291p">https://doi.org/10.1021/tx200291p</a></li>
<li class="show">Noël, J. C., Thiry, L., Verhest, A., Deschepper, N., Peny, M.-O., Sattar, A. A., . . . Haot, J. (1994). Transitional cell carcinoma of the bladder: Evaluation of the role of human papillomaviruses. Urology, 44(5), 671–675. <a href="https://doi.org/10.1016/S0090-4295(94)80202-5">https://doi.org/10.1016/S0090-4295(94)80202-5</a></li>
<li class="show">Pakzad, R., Mohammadian-Hafshejani, A., Mohammadian, M., Pakzad, I., Safiri, S., Khazaei, S., & Salehiniya, H. (2015). Incidence and mortality of bladder cancer and their relationship with development in Asia. Asian Pacific Journal of Cancer Prevention, 16(16), 7365–7374. <a href="https://doi.org/10.7314/APJCP.2015.16.16.7365">https://doi.org/10.7314/APJCP.2015.16.16.7365</a></li>
<li class="show">Pannek, J. (2002). Transitional cell carcinoma in patients with spinal cord injury: A high risk malignancy? Urology, 59(2), 240–244. <a href="https://doi.org/10.1016/S0090-4295(01)01495-9">https://doi.org/10.1016/S0090-4295(01)01495-9</a></li>
<li class="show">Peralta-Videa, J. R., Lopez, M. L., Narayan, M., Saupe, G., & Gardea-Torresdey, J. (2009). The biochemistry of environmental heavy metal uptake by plants: Implications for the food chain. The International Journal of Biochemistry & Cell Biology, 41(8-9), 1665–1677. <a href="https://doi.org/10.1016/j.biocel.2009.03.005">https://doi.org/10.1016/j.biocel.2009.03.005</a></li>
<li class="show">Pira, E., Piolatto, G., Negri, E., Romano, C., Boffetta, P., Lipworth, L., . . . La Vecchia, C. (2010). Bladder cancer mortality of workers exposed to aromatic amines: A 58-year follow-up. Journal of the National Cancer Institute, 102(14), 1096–1099.<a href=" https://doi.org/10.1093/jnci/djq214"> https://doi.org/10.1093/jnci/djq214</a></li>
<li class="show">Ranasinghe, W. K., De Silva, D., De Silva, M. V., Ranasinghe, T. I., Lawrentschuk, N., Bolton, D., & Persad, R. (2012). Incidence of bladder cancer in sri lanka: Analysis of the cancer registry data and review of the incidence of bladder cancer in the South asian population. Korean Journal of Urology, 53(5), 304–309.<a href=" https://doi.org/10.4111/kju.2012.53.5.304"> https://doi.org/10.4111/kju.2012.53.5.304</a></li>
<li class="show">Reid, L. M., Leav, I., Kwan, P. W., Russell, P., & Merk, F. B. (1984). Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice. Cancer Research, 44(10), 4560–4573.</li>
<li class="show">Ros, M. M., Bas Bueno-de-Mesquita, H. B., Büchner, F. L., Aben, K. K., Kampman, E., Egevad, L., . . . Riboli, E. (2011). Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC). International Journal of Cancer, 128(11), 2695–2708. <a href="https://doi.org/10.1002/ijc.25592">https://doi.org/10.1002/ijc.25592</a></li>
<li class="show">Scosyrev, E., Noyes, K., Feng, C., & Messing, E. (2009). Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer, 115(1), 68–74.<a href=" https://doi.org/10.1002/cncr.23986"> https://doi.org/10.1002/cncr.23986</a></li>
<li class="show">Shamseddine, A., Saleh, A., Charafeddine, M., Seoud, M., Mukherji, D., Temraz, S., & Sibai, A. M. (2014). Cancer trends in Lebanon: A review of incidence rates for the period of 2003-2008 and projections until 2018. Population Health Metrics, 12(1), 4. <a href="https://doi.org/10.1186/1478-7954-12-4">https://doi.org/10.1186/1478-7954-12-4</a></li>
<li class="show">Sievert, K. D., Amend, B., Nagele, U., Schilling, D., Bedke, J., Horstmann, M., . . . Stenzl, A. (2009). Economic aspects of bladder cancer: What are the benefits and costs? World Journal of Urology, 27(3), 295–300. <a href="https://doi.org/10.1007/s00345-009-0395-z">https://doi.org/10.1007/s00345-009-0395-z</a></li>
<li class="show">Simone, G., & Gallucci, M. (2012). Multimodality treatment versus radical cystectomy: bladder sparing at cost of life? Elsevier.</li>
<li class="show">Steinmaus, C., Yuan, Y., Bates, M. N., & Smith, A. H. (2003). Case-control study of bladder cancer and drinking water arsenic in the western United States. American Journal of Epidemiology, 158(12), 1193–1201. <a href="https://doi.org/10.1093/aje/kwg281">https://doi.org/10.1093/aje/kwg281</a></li>
<li class="show">Sylvester, R. J. (2011). How well can you actually predict which non-muscle-invasive bladder cancer patients will progress? European Urology, 60(3), 431–433. <a href="https://doi.org/10.1016/j.eururo.2011.06.001">https://doi.org/10.1016/j.eururo.2011.06.001</a></li>
<li class="show">Tapio, S., & Grosche, B. (2006). Arsenic in the aetiology of cancer. Mutation Research/Reviews in Mutation Research, 612(3), 215–246. <a href="https://doi.org/10.1016/j.mrrev.2006.02.001">https://doi.org/10.1016/j.mrrev.2006.02.001</a></li>
<li class="show">Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., & Jemal, A. (2015). Global cancer statistics, 2012. CA: a Cancer Journal for Clinicians, 65(2), 87–108. <a href="https://doi.org/10.3322/caac.21262">https://doi.org/10.3322/caac.21262</a></li>
<li class="show">Vajdic, C. M., McDonald, S. P., McCredie, M. R., van Leeuwen, M. T., Stewart, J. H., Law, M., . . . Grulich, A. E. (2006). Cancer incidence before and after kidney transplantation. Journal of the American Medical Association, 296(23), 2823–2831. <a href="https://doi.org/10.1001/jama.296.23.2823">https://doi.org/10.1001/jama.296.23.2823</a></li>
<li class="show">Volanis, D., Kadiyska, T., Galanis, A., Delakas, D., Logotheti, S., & Zoumpourlis, V. (2010). Environmental factors and genetic susceptibility promote urinary bladder cancer. Toxicology Letters, 193(2), 131–137. <a href="https://doi.org/10.1016/j.toxlet.2009.12.018">https://doi.org/10.1016/j.toxlet.2009.12.018</a><br>W., P. (2001). Nitrate in drinking water and human health. Iowa City. Center for Health Effects of Environmental Contamination.</li>
<li class="show">Ward, M. H., Cantor, K. P., Riley, D., Merkle, S., & Lynch, C. F. (2003). Nitrate in public water supplies and risk of bladder cancer. Epidemiology (Cambridge, Mass.), 14(2), 183–190. <a href="https://doi.org/10.1097/01.EDE.0000050664.28048.DF">https://doi.org/10.1097/01.EDE.0000050664.28048.DF</a></li>
<li class="show">Weyer, P. J., Cerhan, J. R., Kross, B. C., Hallberg, G. R., Kantamneni, J., Breuer, G., . . . Lynch, C. F. (2001). Municipal drinking water nitrate level and cancer risk in older women: The Iowa Women’s Health Study. Epidemiology (Cambridge, Mass.), 12(3), 327–338. <a href="https://doi.org/10.1097/00001648-200105000-00013">https://doi.org/10.1097/00001648-200105000-00013</a></li>
<li class="show">Yee, D. S., Ishill, N. M., Lowrance, W. T., Herr, H. W., & Elkin, E. B. (2011). Ethnic differences in bladder cancer survival. Urology, 78(3), 544–549. <a href="https://doi.org/10.1016/j.urology.2011.02.042">https://doi.org/10.1016/j.urology.2011.02.042</a></li>
<li class="show">Youshya, S., Purdie, K., Breuer, J., Proby, C., Sheaf, M. T., Oliver, R. T., & Baithun, S. (2005). Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. Journal of Clinical Pathology, 58(2), 207–210. <a href="https://doi.org/10.1136/jcp.2004.017152">https://doi.org/10.1136/jcp.2004.017152</a></li>
<li class="show">Zeegers, M. P., Kellen, E., Buntinx, F., & van den Brandt, P. A. (2004). The association between smoking, beverage consumption, diet and bladder cancer: A systematic literature review. World Journal of Urology, 21(6), 392–401. <a href="https://doi.org/10.1007/s00345-003-0382-8">https://doi.org/10.1007/s00345-003-0382-8</a></li>
<li class="show">Zeegers, M. P., Selen, R. F., Kleinjans, J. C., Goldbohm, R. A., & van den Brandt, P. A. (2006). Nitrate intake does not influence bladder cancer risk: The Netherlands cohort study. Environmental Health Perspectives, 114(10), 1527–1531. <a href="https://doi.org/10.1289/ehp.9098">https://doi.org/10.1289/ehp.9098</a></li>
<li class="show">Zhang, H., Jiang, H., Wu, Z., Fang, Z., Fan, J., & Ding, Q. (2013). Primary adenocarcinoma of the urinary bladder: A single site analysis of 21 cases. International Urology and Nephrology, 45(1), 107–111.<a href=" https://doi.org/10.1007/s11255-012-0305-y"> https://doi.org/10.1007/s11255-012-0305-y</a></li>
</ol>
<li class="show">[Internet] (2017). Bladder Cancer . The Scripps Research Institute.</li>
<li class="show">Abern, M.R., Dude, A.M., Tsivian, M., and Coogan, C.L. (2013). The characteristics of bladder cancer after radiotherapy for prostate cancer. Paper presented at: Urologic Oncology: Seminars and Original Investigations (Elsevier). <a href="https://doi.org/10.1016/j.urolonc.2012.04.006">https://doi.org/10.1016/j.urolonc.2012.04.006</a></li>
<li class="show">Aglianò, A. M., Gradilone, A., Gazzaniga, P., Napolitano, M., Vercillo, R., Albonici, L., . . . Vecchione, A. (1994). High frequency of human papillomavirus detection in urinary bladder cancer. Urologia Internationalis, 53(3), 125–129. <a href="https://doi.org/10.1159/000282652">https://doi.org/10.1159/000282652</a></li>
<li class="show">Alberg, A. J., & Hébert, J. R. (2009). Cigarette smoking and bladder cancer: a new twist in an old saga? Oxford University Press.</li>
<li class="show">Amin, M. B., Smith, S. C., Eble, J. N., Rao, P., Choi, W. W., Tamboli, P., & Young, R. H. (2014). Glandular neoplasms of the urachus: A report of 55 cases emphasizing mucinous cystic tumors with proposed classification. The American Journal of Surgical Pathology, 38(8), 1033–1045.</li>
<li class="show">Antoni, S., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A., & Bray, F. (2017). Bladder cancer incidence and mortality: A global overview and recent trends. European Urology, 71(1), 96–108. <a href="https://doi.org/10.1016/j.eururo.2016.06.010">https://doi.org/10.1016/j.eururo.2016.06.010</a></li>
<li class="show">Baithun, S., Daruwala, P., & Oliver, R. T. (1998). Squamous change in bladder cancer and its relevance to understanding clonal evolution in development of bladder cancer. Cancer Surveys, 31, 17–27.</li>
<li class="show">Barghi, M. R., Rahjoo, T., Borghei, M., Hosseini-Moghaddam, S. M., Amani, D., & Farrokhi, B. (2012). Association between the evidence of human papilloma virus infection in bladder transitional cell carcinoma in men and cervical dysplasia in their spouses. Archives of Iranian Medicine, 15(9), 572–574.</li>
<li class="show">Baris, D., Karagas, M. R., Verrill, C., Johnson, A., Andrew, A. S., Marsit, C. J., . . . Silverman, D. T. (2009). A case-control study of smoking and bladder cancer risk: Emergent patterns over time. Journal of the National Cancer Institute, 101(22), 1553–1561.<a href=" https://doi.org/10.1093/jnci/djp361"> https://doi.org/10.1093/jnci/djp361</a></li>
<li class="show">Bosetti, C., Bertuccio, P., Chatenoud, L., Negri, E., La Vecchia, C., & Levi, F. (2011). Trends in mortality from urologic cancers in Europe, 1970-2008. European Urology, 60(1), 1–15. <a href="https://doi.org/10.1016/j.eururo.2011.03.047">https://doi.org/10.1016/j.eururo.2011.03.047</a></li>
<li class="show">Botelho, M., Ferreira, A. C., Oliveira, M. J., Domingues, A., Machado, J. C., & da Costa, J. M. C. (2009). Schistosoma haematobium total antigen induces increased proliferation, migration and invasion, and decreases apoptosis of normal epithelial cells. International Journal for Parasitology, 39(10), 1083–1091. <a href="https://doi.org/10.1016/j.ijpara.2009.02.016">https://doi.org/10.1016/j.ijpara.2009.02.016</a></li>
<li class="show">Botelho, M.C., Oliveira, P.A., Lopes, C., da Costa, J.M.C., and Machado, J.C. (2011). Urothelial dysplasia and inflammation induced by Schistosoma haematobium total antigen instillation in mice normal urothelium. Paper presented at: Urologic Oncology: Seminars and Original Investigations (Elsevier). <a href="https://doi.org/10.1016/j.urolonc.2009.09.017">https://doi.org/10.1016/j.urolonc.2009.09.017</a></li>
<li class="show">Brinkman, M. T., Karagas, M. R., Zens, M. S., Schned, A., Reulen, R. C., & Zeegers, M. P. (2010). Minerals and vitamins and the risk of bladder cancer: Results from the New Hampshire Study. Cancer Causes & Control, 21(4), 609–619. <a href="https://doi.org/10.1007/s10552-009-9490-0">https://doi.org/10.1007/s10552-009-9490-0</a></li>
<li class="show">Brown, A.P., Neeley, E.S., Werner, T., Soisson, A.P., Burt, R.W., and Gaffney, D.K. (2010). A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations. International Journal of Radiation Oncology* Biology* Physics 78, 127-135.<a href=" https://doi.org/10.1016/j.ijrobp.2009.07.1692"> https://doi.org/10.1016/j.ijrobp.2009.07.1692</a></li>
<li class="show">Burger, M., Catto, J. W., Dalbagni, G., Grossman, H. B., Herr, H., Karakiewicz, P., . . . Lotan, Y. (2013). Epidemiology and risk factors of urothelial bladder cancer. European Urology, 63(2), 234–241. <a href="https://doi.org/10.1016/j.eururo.2012.07.033">https://doi.org/10.1016/j.eururo.2012.07.033</a></li>
<li class="show">Carreón, T., Hein, M. J., Viet, S. M., Hanley, K. W., Ruder, A. M., & Ward, E. M. (2010). Increased bladder cancer risk among workers exposed to o-toluidine and aniline: A reanalysis. Occupational and Environmental Medicine, 67(5), 348–350. <a href="https://doi.org/10.1136/oem.2009.051136">https://doi.org/10.1136/oem.2009.051136</a></li>
<li class="show">Case, R. A., & Hosker, M. E. (1954). Tumour of the urinary bladder as an occupational disease in the rubber industry in England and Wales. British Journal of Preventive & Social Medicine, 8(2), 39–50.<br>Chavan, S., Bray, F., Lortet-Tieulent, J., Goodman, M., & Jemal, A. (2014). International variations in bladder cancer incidence and mortality. European Urology, 66(1), 59–73. <a href="https://doi.org/10.1016/j.eururo.2013.10.001">https://doi.org/10.1016/j.eururo.2013.10.001</a></li>
<li class="show">Chen, C.-H., Dickman, K. G., Moriya, M., Zavadil, J., Sidorenko, V. S., Edwards, K. L., . . . Grollman, A. P. (2012). Aristolochic acid-associated urothelial cancer in Taiwan. Proceedings of the National Academy of Sciences of the United States of America, 109(21), 8241–8246.<a href=" https://doi.org/10.1073/pnas.1119920109"> https://doi.org/10.1073/pnas.1119920109</a></li>
<li class="show">Chen, C. H., Dickman, K. G., Huang, C. Y., Moriya, M., Shun, C. T., Tai, H. C., . . . Pu, Y. S. (2013). Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes. International Journal of Cancer, 133(1), 14–20. <a href="https://doi.org/10.1002/ijc.28013">https://doi.org/10.1002/ijc.28013</a></li>
<li class="show">Chen, H.-I., Chi, T.-C., Ko, S.-Y., Hsu, Y.-C., Lin, I.-H., Chen, A., . . . Li, C.-F. (2014). 4, 4′-Methylenebis (2-chloroaniline)(MBOCA) May Be Highly Toxic and a Carcinogen Based on an Experimental Study with Mice. Advances in Biological Chemistry, 4(03), 203–213. <a href="https://doi.org/10.4236/abc.2014.43025">https://doi.org/10.4236/abc.2014.43025</a></li>
<li class="show">Chen, W., Clements, M., Rahman, B., Zhang, S., Qiao, Y., & Armstrong, B. K. (2010). Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China. Cancer Causes & Control, 21(10), 1701–1709. <a href="https://doi.org/10.1007/s10552-010-9599-1">https://doi.org/10.1007/s10552-010-9599-1</a></li>
<li class="show">Chiu, H.-F., Tsai, S.-S., & Yang, C.-Y. (2007). Nitrate in drinking water and risk of death from bladder cancer: An ecological case-control study in Taiwan. Journal of Toxicology and Environmental Health. Part A., 70(12), 1000–1004. <a href="https://doi.org/10.1080/15287390601171801">https://doi.org/10.1080/15287390601171801</a></li>
<li class="show">Chow, W.-H., Dong, L. M., & Devesa, S. S. (2010). Epidemiology and risk factors for kidney cancer. Nature Reviews. Urology, 7(5), 245–257. <a href="https://doi.org/10.1038/nrurol.2010.46">https://doi.org/10.1038/nrurol.2010.46</a></li>
<li class="show">Clyne, M. (2013). Bladder cancer: Aristolochic acid—one of the most potent carcinogens known to man. Nature Reviews. Urology, 10(10), 552–552. <a href="https://doi.org/10.1038/nrurol.2013.186">https://doi.org/10.1038/nrurol.2013.186</a></li>
<li class="show">Colombel, M., Soloway, M., Akaza, H., Böhle, A., Palou, J., Buckley, R., Lamm, D., Brausi, M., Witjes, J.A., and Persad, R. (2008). Epidemiology, staging, grading, and risk stratification of bladder cancer. european urology supplements 7, 618-626.</li>
<li class="show">Colt, J.S., Karagas, M.R., Schwenn, M., Baris, D., Johnson, A., Stewart, P., Verrill, C., Moore, L.E., Lubin, J., and Ward, M.H. (2010). Occupation and bladder cancer in a population-based case–control study in Northern New England. Occupational and environmental medicine, oem. 2009.052571.</li>
<li class="show">Datta, G. D., Neville, B. A., Kawachi, I., Datta, N. S., & Earle, C. C. (2009). Marital status and survival following bladder cancer. Journal of Epidemiology and Community Health, 63(10), 807–813. <a href="https://doi.org/10.1136/jech.2008.082438">https://doi.org/10.1136/jech.2008.082438</a></li>
<li class="show">Davis-Dao, C.A., Henderson, K.D., Sullivan-Halley, J., Ma, H., West, D.W., Xiang, Y.-B., Gago-Dominguez, M., Stern, M.C., Castelao, J.E., and Conti, D.V. (2011). Lower risk in parous women suggests hormonal factors important in bladder cancer etiology. Cancer Epidemiology and Prevention Biomarkers, cebp. 0017.2011. <a href="https://doi.org/10.1158/1055-9965.EPI-11-0017">https://doi.org/10.1158/1055-9965.EPI-11-0017</a></li>
<li class="show">Dietrich, K., Demidenko, E., Schned, A., Zens, M. S., Heaney, J., & Karagas, M. R. (2011). Parity, early menopause and the incidence of bladder cancer in women: A case-control study and meta-analysis. European Journal of Cancer, 47(4), 592–599. <a href="https://doi.org/10.1016/j.ejca.2010.10.007">https://doi.org/10.1016/j.ejca.2010.10.007</a></li>
<li class="show">Emadi, A., Jones, R. J., & Brodsky, R. A. (2009). Cyclophosphamide and cancer: Golden anniversary. Nature Reviews. Clinical Oncology, 6(11), 638–647. <a href="https://doi.org/10.1038/nrclinonc.2009.146">https://doi.org/10.1038/nrclinonc.2009.146</a></li>
<li class="show">Escudero, D. O., Shirodkar, S. P., & Lokeshwar, V. B. (2011). Bladder carcinogenesis and molecular pathways. In Bladder Tumors (pp. 23–41). Springer. <a href="https://doi.org/10.1007/978-1-60761-928-4_2">https://doi.org/10.1007/978-1-60761-928-4_2</a></li>
<li class="show">Feifer, A. H., Taylor, J. M., Tarin, T. V., & Herr, H. W. (2011). Maximizing cure for muscle-invasive bladder cancer: Integration of surgery and chemotherapy. European Urology, 59(6), 978–984. <a href="https://doi.org/10.1016/j.eururo.2011.01.014">https://doi.org/10.1016/j.eururo.2011.01.014</a></li>
<li class="show">Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W., Comber, H., . . . Bray, F. (2013). Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer, 49(6), 1374–1403. <a href="https://doi.org/10.1016/j.ejca.2012.12.027">https://doi.org/10.1016/j.ejca.2012.12.027</a></li>
<li class="show">Fernández, M. I., López, J. F., Vivaldi, B., & Coz, F. (2012). Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure. The Journal of Urology, 187(3), 856–861. <a href="https://doi.org/10.1016/j.juro.2011.10.157">https://doi.org/10.1016/j.juro.2011.10.157</a></li>
<li class="show">Figueroa, J. D., Koutros, S., Colt, J. S., Kogevinas, M., Garcia-Closas, M., Real, F. X., . . . Silverman, D. T. (2015). Modification of occupational exposures on bladder cancer risk by common genetic polymorphisms. JNCI. Journal of the National Cancer Institute, 107(11), 107.<a href=" https://doi.org/10.1093/jnci/djv223"> https://doi.org/10.1093/jnci/djv223</a></li>
<li class="show">Freedman, N. D., Silverman, D. T., Hollenbeck, A. R., Schatzkin, A., & Abnet, C. C. (2011). Association between smoking and risk of bladder cancer among men and women. Journal of the American Medical Association, 306(7), 737–745. <a href="https://doi.org/10.1001/jama.2011.1142">https://doi.org/10.1001/jama.2011.1142</a></li>
<li class="show">Gago-Dominguez, M., Castelao, J. E., Yuan, J. M., Yu, M. C., & Ross, R. K. (2001). Use of permanent hair dyes and bladder-cancer risk. International Journal of Cancer, 91(4), 575–579. <a href="https://doi.org/10.1002/1097-0215(200002)9999:99993.0.CO;2-S">https://doi.org/10.1002/1097-0215(200002)9999:99993.0.CO;2-S</a></li>
<li class="show">García-Pérez, J., Pollán, M., Boldo, E., Pérez-Gómez, B., Aragonés, N., Lope, V., . . . López-Abente, G. (2009). Mortality due to lung, laryngeal and bladder cancer in towns lying in the vicinity of combustion installations. The Science of the Total Environment, 407(8), 2593–2602. <a href="https://doi.org/10.1016/j.scitotenv.2008.12.062">https://doi.org/10.1016/j.scitotenv.2008.12.062</a></li>
<li class="show">Garland, C., Shekelle, R. B., Barrett-Connor, E., Criqui, M. H., Rossof, A. H., & Paul, O. (1985). Dietary vitamin D and calcium and risk of colorectal cancer: A 19-year prospective study in men. Lancet, 1(8424), 307–309. <a href="https://doi.org/10.1016/S0140-6736(85)91082-7">https://doi.org/10.1016/S0140-6736(85)91082-7</a></li>
<li class="show">Giron, A. M., Passerotti, C. C., Nguyen, H., Cruz, J. A., & Srougi, M. (2011). Bladder exstrophy: Reconstructed female patients achieving normal pregnancy and delivering normal babies. International Braz J Urol, 37(5), 605–610. <a href="https://doi.org/10.1590/S1677-55382011000500006">https://doi.org/10.1590/S1677-55382011000500006</a></li>
<li class="show">Golka, K., Wiese, A., Assennato, G., & Bolt, H. M. (2004). Occupational exposure and urological cancer. World Journal of Urology, 21(6), 382–391. <a href="https://doi.org/10.1007/s00345-003-0377-5">https://doi.org/10.1007/s00345-003-0377-5</a></li>
<li class="show">Gulis, G., Czompolyova, M., & Cerhan, J. R. (2002). An ecologic study of nitrate in municipal drinking water and cancer incidence in Trnava District, Slovakia. Environmental Research, 88(3), 182–187. <a href="https://doi.org/10.1006/enrs.2002.4331">https://doi.org/10.1006/enrs.2002.4331</a></li>
<li class="show">Husain, E., Prowse, D. M., Ktori, E., Shaikh, T., Yaqoob, M., Junaid, I., & Baithun, S. (2009). Human papillomavirus is detected in transitional cell carcinoma arising in renal transplant recipients. Pathology, 41(3), 245–247. <a href="https://doi.org/10.1080/00313020902756303">https://doi.org/10.1080/00313020902756303</a></li>
<li class="show">Jacobs, B. L., Lee, C. T., & Montie, J. E. (2010). Bladder cancer in 2010: How far have we come? CA: a Cancer Journal for Clinicians, 60(4), 244–272. <a href="https://doi.org/10.3322/caac.20077">https://doi.org/10.3322/caac.20077</a></li>
<li class="show">Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: a Cancer Journal for Clinicians, 61(2), 69–90. <a href="https://doi.org/10.3322/caac.20107">https://doi.org/10.3322/caac.20107</a></li>
<li class="show">Jemal, A., Center, M. M., DeSantis, C., & Ward, E. M. (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology and Prevention Biomarkers, 19(8), 1893–1907. <a href="https://doi.org/10.1158/1055-9965.EPI-10-0437">https://doi.org/10.1158/1055-9965.EPI-10-0437</a></li>
<li class="show">Jomova, K., Jenisova, Z., Feszterova, M., Baros, S., Liska, J., Hudecova, D., . . . Valko, M. (2011). Arsenic: Toxicity, oxidative stress and human disease. Journal of Applied Toxicology, 31(2), 95–107.</li>
<li class="show">Karagas, M. R., Park, S., Warren, A., Hamilton, J., Nelson, H. H., Mott, L. A., & Kelsey, K. T. (2005). Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: A population-based study. Cancer Letters, 219(1), 63–69. <a href="https://doi.org/10.1016/j.canlet.2004.10.006">https://doi.org/10.1016/j.canlet.2004.10.006</a></li>
<li class="show">Kiemeney, L. A., Sulem, P., Besenbacher, S., Vermeulen, S. H., Sigurdsson, A., Thorleifsson, G., . . . Stefansson, K. (2010). A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nature Genetics, 42(5), 415–419. <a href="https://doi.org/10.1038/ng.558">https://doi.org/10.1038/ng.558</a></li>
<li class="show">Kiriluk, K.J., Prasad, S.M., Patel, A.R., Steinberg, G.D., and Smith, N.D. (2012). Bladder cancer risk from occupational and environmental exposures. Paper presented at: Urologic Oncology: Seminars and Original Investigations (Elsevier). <a href="https://doi.org/10.1016/j.urolonc.2011.10.010">https://doi.org/10.1016/j.urolonc.2011.10.010</a></li>
<li class="show">Kirkali, Z., Chan, T., Manoharan, M., Algaba, F., Busch, C., Cheng, L., . . . Weider, J. (2005). Bladder cancer: Epidemiology, staging and grading, and diagnosis. Urology, 66(6, Suppl 1), 4–34. <a href="https://doi.org/10.1016/j.urology.2005.07.062">https://doi.org/10.1016/j.urology.2005.07.062</a></li>
<li class="show">Koay, E. J., Teh, B. S., Paulino, A. C., & Butler, E. B. (2011). A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: Epidemiology, prognostic variables, and treatment trends. Cancer, 117(23), 5325–5333. <a href="https://doi.org/10.1002/cncr.26197">https://doi.org/10.1002/cncr.26197</a></li>
<li class="show">Kogevinas M, G.-C.M. (2014). Bladder cancer. In Occupational Cancers (Springer), pp. 461-480.</li>
<li class="show">Koroukian, S., Bakkaki, P., and Raghavan, D. (2010). Survival disparities by Medicaid status: An analysis of 8 cancers [abstract A-62]. Paper presented at: American Association of Cancer Research Annual Meeting, Miami, Florida.</li>
<li class="show">Lee, R. K., Abol-Enein, H., Artibani, W., Bochner, B., Dalbagni, G., Daneshmand, S., . . . Shariat, S. F. (2014). Urinary diversion after radical cystectomy for bladder cancer: Options, patient selection, and outcomes. BJU International, 113(1), 11–23. <a href="https://doi.org/10.1111/bju.12121">https://doi.org/10.1111/bju.12121</a></li>
<li class="show">Letašiová, S., Medve’ová, A., Šovčíková, A., Dušinská, M., Volkovová, K., Mosoiu, C., & Bartonová, A. (2012). Bladder cancer, a review of the environmental risk factors. Environmental Health, 11(Suppl 1), S11. <a href="https://doi.org/10.1186/1476-069X-11-S1-S11">https://doi.org/10.1186/1476-069X-11-S1-S11</a></li>
<li class="show">Levin, D., Bell, S., Sund, R., Hartikainen, S. A., Tuomilehto, J., Pukkala, E., . . . Colhoun, H. M., & the Scottish Diabetes Research Network Epidemiology Group, & the Diabetes and Cancer Research Consortium. (2015). Pioglitazone and bladder cancer risk: A multipopulation pooled, cumulative exposure analysis. Diabetologia, 58(3), 493–504. <a href="https://doi.org/10.1007/s00125-014-3456-9">https://doi.org/10.1007/s00125-014-3456-9</a></li>
<li class="show">Lewis, J. D., Ferrara, A., Peng, T., Hedderson, M., Bilker, W. B., Quesenberry, C. P., Jr., . . . Strom, B. L. (2011). Risk of bladder cancer among diabetic patients treated with pioglitazone: Interim report of a longitudinal cohort study. Diabetes Care, 34(4), 916–922. <a href="https://doi.org/10.2337/dc10-1068">https://doi.org/10.2337/dc10-1068</a></li>
<li class="show">Li, N., Yang, L., Zhang, Y., Zhao, P., Zheng, T., & Dai, M. (2011). Human papillomavirus infection and bladder cancer risk: A meta-analysis. The Journal of Infectious Diseases, 204(2), 217–223. <a href="https://doi.org/10.1093/infdis/jir248">https://doi.org/10.1093/infdis/jir248</a></li>
<li class="show">Lin, I.-S., Fan, P.-L., Chen, H.-I., Loh, C.-H., Shih, T.-S., & Liou, S.-H. (2013). Rapid and intermediate N-acetylators are less susceptible to oxidative damage among 4,4′-methylenebis(2-chloroaniline) (MBOCA)-exposed workers. International Journal of Hygiene and Environmental Health, 216(4), 515–520. <a href="https://doi.org/10.1016/j.ijheh.2013.02.001">https://doi.org/10.1016/j.ijheh.2013.02.001</a></li>
<li class="show">Mahdavifar, N., Ghoncheh, M., Pakzad, R., Momenimovahed, Z., & Salehiniya, H. (2016). Epidemiology, incidence and mortality of bladder cancer and their relationship with the development index in the world. Asian Pacific Journal of Cancer Prevention, 17(1), 381–386. <a href="https://doi.org/10.7314/APJCP.2016.17.1.381">https://doi.org/10.7314/APJCP.2016.17.1.381</a></li>
<li class="show">Melick, W. F., Escue, H. M., Naryka, J. J., Mezera, R. A., & Wheeler, E. P. (1955). The first reported cases of human bladder tumors due to a new carcinogen-xenylamine. The Journal of Urology, 74(6), 760–766. <a href="https://doi.org/10.1016/S0022-5347(17)67344-0">https://doi.org/10.1016/S0022-5347(17)67344-0</a></li>
<li class="show">Meliker, J. R., Slotnick, M. J., AvRuskin, G. A., Schottenfeld, D., Jacquez, G. M., Wilson, M. L., . . . Nriagu, J. O. (2010). Lifetime exposure to arsenic in drinking water and bladder cancer: A population-based case-control study in Michigan, USA. Cancer Causes & Control, 21(5), 745–757. <a href="https://doi.org/10.1007/s10552-010-9503-z">https://doi.org/10.1007/s10552-010-9503-z</a></li>
<li class="show">Miao, Y., Everly, J. J., Gross, T. G., Tevar, A. D., First, M. R., Alloway, R. R., & Woodle, E. S. (2009). De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation, 87(9), 1347–1359. <a href="https://doi.org/10.1097/TP.0b013e3181a238f6">https://doi.org/10.1097/TP.0b013e3181a238f6</a></li>
<li class="show">Mohr, S. B., Garland, C. F., Gorham, E. D., Grant, W. B., & Garland, F. C. (2010). Ultraviolet B irradiance and incidence rates of bladder cancer in 174 countries. American Journal of Preventive Medicine, 38(3), 296–302. <a href="https://doi.org/10.1016/j.amepre.2009.10.044">https://doi.org/10.1016/j.amepre.2009.10.044</a></li>
<li class="show">Monach, P. A., Arnold, L. M., & Merkel, P. A. (2010). Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: A data-driven review. Arthritis & Rheumatology (Hoboken, N.J.), 62(1), 9–21. <a href="https://doi.org/10.1002/art.25061">https://doi.org/10.1002/art.25061</a></li>
<li class="show">Naranmandura, H., Carew, M. W., Xu, S., Lee, J., Leslie, E. M., Weinfeld, M., & Le, X. C. (2011). Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells. Chemical Research in Toxicology, 24(9), 1586–1596. <a href="https://doi.org/10.1021/tx200291p">https://doi.org/10.1021/tx200291p</a></li>
<li class="show">Noël, J. C., Thiry, L., Verhest, A., Deschepper, N., Peny, M.-O., Sattar, A. A., . . . Haot, J. (1994). Transitional cell carcinoma of the bladder: Evaluation of the role of human papillomaviruses. Urology, 44(5), 671–675. <a href="https://doi.org/10.1016/S0090-4295(94)80202-5">https://doi.org/10.1016/S0090-4295(94)80202-5</a></li>
<li class="show">Pakzad, R., Mohammadian-Hafshejani, A., Mohammadian, M., Pakzad, I., Safiri, S., Khazaei, S., & Salehiniya, H. (2015). Incidence and mortality of bladder cancer and their relationship with development in Asia. Asian Pacific Journal of Cancer Prevention, 16(16), 7365–7374. <a href="https://doi.org/10.7314/APJCP.2015.16.16.7365">https://doi.org/10.7314/APJCP.2015.16.16.7365</a></li>
<li class="show">Pannek, J. (2002). Transitional cell carcinoma in patients with spinal cord injury: A high risk malignancy? Urology, 59(2), 240–244. <a href="https://doi.org/10.1016/S0090-4295(01)01495-9">https://doi.org/10.1016/S0090-4295(01)01495-9</a></li>
<li class="show">Peralta-Videa, J. R., Lopez, M. L., Narayan, M., Saupe, G., & Gardea-Torresdey, J. (2009). The biochemistry of environmental heavy metal uptake by plants: Implications for the food chain. The International Journal of Biochemistry & Cell Biology, 41(8-9), 1665–1677. <a href="https://doi.org/10.1016/j.biocel.2009.03.005">https://doi.org/10.1016/j.biocel.2009.03.005</a></li>
<li class="show">Pira, E., Piolatto, G., Negri, E., Romano, C., Boffetta, P., Lipworth, L., . . . La Vecchia, C. (2010). Bladder cancer mortality of workers exposed to aromatic amines: A 58-year follow-up. Journal of the National Cancer Institute, 102(14), 1096–1099.<a href=" https://doi.org/10.1093/jnci/djq214"> https://doi.org/10.1093/jnci/djq214</a></li>
<li class="show">Ranasinghe, W. K., De Silva, D., De Silva, M. V., Ranasinghe, T. I., Lawrentschuk, N., Bolton, D., & Persad, R. (2012). Incidence of bladder cancer in sri lanka: Analysis of the cancer registry data and review of the incidence of bladder cancer in the South asian population. Korean Journal of Urology, 53(5), 304–309.<a href=" https://doi.org/10.4111/kju.2012.53.5.304"> https://doi.org/10.4111/kju.2012.53.5.304</a></li>
<li class="show">Reid, L. M., Leav, I., Kwan, P. W., Russell, P., & Merk, F. B. (1984). Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice. Cancer Research, 44(10), 4560–4573.</li>
<li class="show">Ros, M. M., Bas Bueno-de-Mesquita, H. B., Büchner, F. L., Aben, K. K., Kampman, E., Egevad, L., . . . Riboli, E. (2011). Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC). International Journal of Cancer, 128(11), 2695–2708. <a href="https://doi.org/10.1002/ijc.25592">https://doi.org/10.1002/ijc.25592</a></li>
<li class="show">Scosyrev, E., Noyes, K., Feng, C., & Messing, E. (2009). Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer, 115(1), 68–74.<a href=" https://doi.org/10.1002/cncr.23986"> https://doi.org/10.1002/cncr.23986</a></li>
<li class="show">Shamseddine, A., Saleh, A., Charafeddine, M., Seoud, M., Mukherji, D., Temraz, S., & Sibai, A. M. (2014). Cancer trends in Lebanon: A review of incidence rates for the period of 2003-2008 and projections until 2018. Population Health Metrics, 12(1), 4. <a href="https://doi.org/10.1186/1478-7954-12-4">https://doi.org/10.1186/1478-7954-12-4</a></li>
<li class="show">Sievert, K. D., Amend, B., Nagele, U., Schilling, D., Bedke, J., Horstmann, M., . . . Stenzl, A. (2009). Economic aspects of bladder cancer: What are the benefits and costs? World Journal of Urology, 27(3), 295–300. <a href="https://doi.org/10.1007/s00345-009-0395-z">https://doi.org/10.1007/s00345-009-0395-z</a></li>
<li class="show">Simone, G., & Gallucci, M. (2012). Multimodality treatment versus radical cystectomy: bladder sparing at cost of life? Elsevier.</li>
<li class="show">Steinmaus, C., Yuan, Y., Bates, M. N., & Smith, A. H. (2003). Case-control study of bladder cancer and drinking water arsenic in the western United States. American Journal of Epidemiology, 158(12), 1193–1201. <a href="https://doi.org/10.1093/aje/kwg281">https://doi.org/10.1093/aje/kwg281</a></li>
<li class="show">Sylvester, R. J. (2011). How well can you actually predict which non-muscle-invasive bladder cancer patients will progress? European Urology, 60(3), 431–433. <a href="https://doi.org/10.1016/j.eururo.2011.06.001">https://doi.org/10.1016/j.eururo.2011.06.001</a></li>
<li class="show">Tapio, S., & Grosche, B. (2006). Arsenic in the aetiology of cancer. Mutation Research/Reviews in Mutation Research, 612(3), 215–246. <a href="https://doi.org/10.1016/j.mrrev.2006.02.001">https://doi.org/10.1016/j.mrrev.2006.02.001</a></li>
<li class="show">Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., & Jemal, A. (2015). Global cancer statistics, 2012. CA: a Cancer Journal for Clinicians, 65(2), 87–108. <a href="https://doi.org/10.3322/caac.21262">https://doi.org/10.3322/caac.21262</a></li>
<li class="show">Vajdic, C. M., McDonald, S. P., McCredie, M. R., van Leeuwen, M. T., Stewart, J. H., Law, M., . . . Grulich, A. E. (2006). Cancer incidence before and after kidney transplantation. Journal of the American Medical Association, 296(23), 2823–2831. <a href="https://doi.org/10.1001/jama.296.23.2823">https://doi.org/10.1001/jama.296.23.2823</a></li>
<li class="show">Volanis, D., Kadiyska, T., Galanis, A., Delakas, D., Logotheti, S., & Zoumpourlis, V. (2010). Environmental factors and genetic susceptibility promote urinary bladder cancer. Toxicology Letters, 193(2), 131–137. <a href="https://doi.org/10.1016/j.toxlet.2009.12.018">https://doi.org/10.1016/j.toxlet.2009.12.018</a><br>W., P. (2001). Nitrate in drinking water and human health. Iowa City. Center for Health Effects of Environmental Contamination.</li>
<li class="show">Ward, M. H., Cantor, K. P., Riley, D., Merkle, S., & Lynch, C. F. (2003). Nitrate in public water supplies and risk of bladder cancer. Epidemiology (Cambridge, Mass.), 14(2), 183–190. <a href="https://doi.org/10.1097/01.EDE.0000050664.28048.DF">https://doi.org/10.1097/01.EDE.0000050664.28048.DF</a></li>
<li class="show">Weyer, P. J., Cerhan, J. R., Kross, B. C., Hallberg, G. R., Kantamneni, J., Breuer, G., . . . Lynch, C. F. (2001). Municipal drinking water nitrate level and cancer risk in older women: The Iowa Women’s Health Study. Epidemiology (Cambridge, Mass.), 12(3), 327–338. <a href="https://doi.org/10.1097/00001648-200105000-00013">https://doi.org/10.1097/00001648-200105000-00013</a></li>
<li class="show">Yee, D. S., Ishill, N. M., Lowrance, W. T., Herr, H. W., & Elkin, E. B. (2011). Ethnic differences in bladder cancer survival. Urology, 78(3), 544–549. <a href="https://doi.org/10.1016/j.urology.2011.02.042">https://doi.org/10.1016/j.urology.2011.02.042</a></li>
<li class="show">Youshya, S., Purdie, K., Breuer, J., Proby, C., Sheaf, M. T., Oliver, R. T., & Baithun, S. (2005). Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. Journal of Clinical Pathology, 58(2), 207–210. <a href="https://doi.org/10.1136/jcp.2004.017152">https://doi.org/10.1136/jcp.2004.017152</a></li>
<li class="show">Zeegers, M. P., Kellen, E., Buntinx, F., & van den Brandt, P. A. (2004). The association between smoking, beverage consumption, diet and bladder cancer: A systematic literature review. World Journal of Urology, 21(6), 392–401. <a href="https://doi.org/10.1007/s00345-003-0382-8">https://doi.org/10.1007/s00345-003-0382-8</a></li>
<li class="show">Zeegers, M. P., Selen, R. F., Kleinjans, J. C., Goldbohm, R. A., & van den Brandt, P. A. (2006). Nitrate intake does not influence bladder cancer risk: The Netherlands cohort study. Environmental Health Perspectives, 114(10), 1527–1531. <a href="https://doi.org/10.1289/ehp.9098">https://doi.org/10.1289/ehp.9098</a></li>
<li class="show">Zhang, H., Jiang, H., Wu, Z., Fang, Z., Fan, J., & Ding, Q. (2013). Primary adenocarcinoma of the urinary bladder: A single site analysis of 21 cases. International Urology and Nephrology, 45(1), 107–111.<a href=" https://doi.org/10.1007/s11255-012-0305-y"> https://doi.org/10.1007/s11255-012-0305-y</a></li>
</ol>
Downloads
Published
2017-09-28
Issue
Section
Review
License
Copyright The Author(s) 2017. This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
How to Cite
Essentials of bladder cancer worldwide: incidence, mortality rate and risk factors. (2017). Biomedical Research and Therapy, 4(9), 1638-1655. https://doi.org/10.15419/bmrat.v4i9.371
